Open AccessComparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension
Author(s) -
Vandana Badar,
Sachin K. Hiware,
Meena Shrivastava,
Vijay Thawani,
Mrunalini M. Hardas
Publication year - 2011
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.83117
Subject(s) - nebivolol , atenolol , essential hypertension , medicine , blood pressure , lipid profile , pharmacology , metabolic syndrome , vasodilation , adverse effect , blood sugar , cardiology , endocrinology , cholesterol , obesity , diabetes mellitus
Nebivolol is a third-generation β-blocker, with highest β(1) selectivity and nitric-oxide-derived vasodilatation. It also exhibits antiproliferative and antioxidant property that has beneficial metabolic profile compared to second-generation β blockers like atenolol. This study was planned to study the comparative effects of nebivolol and atenolol on metabolic parameters in patients with essential hypertension.